These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18301458)

  • 21. A concurrent chemoirradiation with cisplatin followed by adjuvant chemotherapy with ifosfamide, 5-fluorouracil, and leucovorin for stage IV nasopharyngeal carcinoma.
    Chua DT; Sham JS; Au GK
    Head Neck; 2004 Feb; 26(2):118-26. PubMed ID: 14762880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction chemotherapy followed by alternating chemo-radiotherapy in stage IV undifferentiated nasopharyngeal carcinoma.
    Benasso M; Sanguineti G; D'Amico M; Corvò R; Ricci I; Numico G; Guarneri D; Vitale V; Pallestrini E; Santelli A; Rosso R
    Br J Cancer; 2000 Dec; 83(11):1437-42. PubMed ID: 11076650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concurrent chemoradiation followed by adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma in Korea.
    Park KH; Kim JS; Park Y; Seo HY; Park YJ; Choi IK; Oh SC; Seo JH; Kim CY; Jung KY; Shin SW; Kim YH; Kim JS; Lee NJ
    Cancer Chemother Pharmacol; 2010 Sep; 66(4):643-51. PubMed ID: 20033411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison of efficacy of docetaxel combined cisplatin (TP regimen) and cisplatin combined 5-fluorouracil (PF regimen) on locally advanced nasopharyngeal carcinoma].
    Xie FY; Qi SN; Hu WH; Zou GR; Peng M; Li JS
    Ai Zheng; 2007 Aug; 26(8):880-4. PubMed ID: 17697552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Examining prognostic factors and patterns of failure in nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy: impact on future clinical trials.
    Cheng SH; Yen KL; Jian JJ; Tsai SY; Chu NM; Leu SY; Chan KY; Tan TD; Cheng JC; Hsieh CY; Huang AT
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):717-26. PubMed ID: 11395240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction chemotherapy followed by concurrent chemoradiotherapy in advanced head and neck squamous cell carcinoma.
    Barone C; Grillo R; Dongiovanni D; Birocco N; Rampino M; Redda MG; Garibaldi E; Munoz F; Pecorari G; Cavalot A; Garzinodemo P; Buffoni L; Ciuffreda L; Ricardi U; Cortesina G; Giordano C; Fasolis M; Berrone S; Bertetto O; Schena M
    Anticancer Res; 2008; 28(2B):1285-91. PubMed ID: 18505067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concurrent chemoradiotherapy with paclitaxel and nedaplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: preliminary results of a phase II study.
    Zhang MQ; Liu SP; Wang XE
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):821-7. PubMed ID: 20207507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concurrent cisplatin/radiation followed by adjuvant cisplatin/paclitaxel in treatment of patients with stage IB grade 3, IC and IIA endometrial carcinoma.
    Foad I; Sharawy I; Mostafa E; Margergis M; Hussein T
    J Egypt Natl Canc Inst; 2007 Jun; 19(2):163-9. PubMed ID: 19034346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paclitaxel, 5-fluorouracil and hydroxyurea concurrent with radiation in locally advanced nasopharyngeal carcinoma.
    Wong AS; Soo RA; Lu JJ; Loh KS; Tan KS; Hsieh WS; Shakespeare TP; Chua ET; Lim HL; Goh BC
    Ann Oncol; 2006 Jul; 17(7):1152-7. PubMed ID: 16684789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II study: concurrent chemo-radiotherapy in advanced nasopharyngeal carcinoma.
    Maoleekoonpairoj S; Phromratanapongse P; Puttanuparp S
    J Med Assoc Thai; 1997 Dec; 80(12):778-84. PubMed ID: 9470331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase II trial of induction NAB-paclitaxel and cisplatin followed by concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma.
    Ke LR; Xia WX; Qiu WZ; Huang XJ; Yu YH; Liang H; Liu GY; Xiang YQ; Guo X; Lv X
    Oral Oncol; 2017 Jul; 70():7-13. PubMed ID: 28622892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma of the undifferentiated type.
    Ong YK; Tan EH; Wee J; Goh CB; Fong KW; Lee KS; Chua EJ
    Ann Acad Med Singap; 1999 Jul; 28(4):525-8. PubMed ID: 10561766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase I/II study of neoadjuvant chemotherapy followed by radiation with boost chemotherapy for advanced T-stage nasopharyngeal carcinoma.
    Johnson FM; Garden AS; Palmer JL; Shin DM; Morrison W; Papadimitrakopoulou V; Khuri F; Clayman G; Goepfert H; Ang KK; Hong WK; Glisson BS
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):717-24. PubMed ID: 16199307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: therapeutic monitoring with plasma Epstein-Barr virus DNA.
    Chan AT; Ma BB; Lo YM; Leung SF; Kwan WH; Hui EP; Mok TS; Kam M; Chan LS; Chiu SK; Yu KH; Cheung KY; Lai K; Lai M; Mo F; Yeo W; King A; Johnson PJ; Teo PM; Zee B
    J Clin Oncol; 2004 Aug; 22(15):3053-60. PubMed ID: 15284255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy with cisplatin and paclitaxel in locally advanced cervical cancer: has this regimen still a role as neoadjuvant setting?
    Moioli M; Papadia A; Mammoliti S; Pacella E; Menoni S; Menada MV; Ragni N
    Minerva Ginecol; 2012 Apr; 64(2):95-107. PubMed ID: 22481620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.
    Al-Sarraf M; LeBlanc M; Giri PG; Fu KK; Cooper J; Vuong T; Forastiere AA; Adams G; Sakr WA; Schuller DE; Ensley JF
    J Clin Oncol; 1998 Apr; 16(4):1310-7. PubMed ID: 9552031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma: results of a matched cohort study.
    Geara FB; Glisson BS; Sanguineti G; Tucker SL; Garden AS; Ang KK; Lippman SM; Clayman GL; Goepfert H; Peters LJ; Hong WK
    Cancer; 1997 Apr; 79(7):1279-86. PubMed ID: 9083147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy of induction chemotherapy in the treatment of stage II nasopharyngeal carcinoma in intensity modulated radiotherapy era.
    Li PJ; Mo HY; Luo DH; Hu WH; Jin T
    Oral Oncol; 2018 Oct; 85():95-100. PubMed ID: 30220326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Concurrent chemoradiation with paclitaxel and platinum for locally advanced esophageal cancer].
    Zhang P; Xie CY; Wu SX
    Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):773-7. PubMed ID: 18396692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concurrent chemo-radiation with or without induction gemcitabine, Carboplatin, and Paclitaxel: a randomized, phase 2/3 trial in locally advanced nasopharyngeal carcinoma.
    Tan T; Lim WT; Fong KW; Cheah SL; Soong YL; Ang MK; Ng QS; Tan D; Ong WS; Tan SH; Yip C; Quah D; Soo KC; Wee J
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):952-60. PubMed ID: 25832687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.